Firefly Neuroscience (AIFF) Accumulated Expenses (2010 - 2026)

Firefly Neuroscience's Accumulated Expenses history runs 16 years deep, the most recent figure standing at $453000.0 for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 60.81% year-over-year to $453000.0; the TTM figure through Mar 2026 stood at $453000.0 (down 60.81% YoY), while the FY2025 annual figure was $766000.0, down 52.89% from the prior year.
• Accumulated Expenses was $453000.0 for Q1 2026 at Firefly Neuroscience, down from $766000.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.9 million in Q4 2023 to a low of $1195.0 in Q4 2022.
• Historically, Accumulated Expenses has averaged $750785.8 across 5 years, with a median of $607788.0 in 2022.
• The sharpest annual moves came in 2023 and 2026: Accumulated Expenses soared 159063.18% in 2023, then slumped 60.81% in 2026.
• A 5-year view of Accumulated Expenses shows it stood at $1195.0 in 2022, then jumped by 159063.18% to $1.9 million in 2023, then declined by 14.51% to $1.6 million in 2024, then plunged by 52.89% to $766000.0 in 2025, then tumbled by 40.86% to $453000.0 in 2026.
• The last three Accumulated Expenses figures came in at $453000.0 (Q1 2026), $766000.0 (Q4 2025), and $658000.0 (Q3 2025), per Business Quant data.